Biotech Deal Volume Increases 58% in Q3:16
Overall, mergers and acquisitions slowed in Q3:16, down 11% compared with Q2:16, and 10% lower than in Q3:15. The biotechnology sector saw just the opposite phenomenon. Biotech transactions grew by 58%, to 52 deals, compared with the previous quarter’s 33 deals, and by 24% compared with the same quarter in 2015, when 42 deals were announced. Not all deals in this sector involve the purchase of an entire company, however. Just 42% of the third-quarter transactions fit that description. The remaining 58% deals involved the purchase of exclusive rights and licenses to products, product candidates or intellectual property from a biotech firm. Pharmaceutical companies have pulled back (or... Read More »Epic Health Expands Pediatric Skilled Nursing Services
The term “skilled nursing” usually brings to mind senior care facilities. Yet Epic Health Services, a portfolio company of Webster Capital, has built a strong platform of pediatric skilled nursing services since its founding in 2001.The Dallas, Texas-based company announced its fifth acquisition of 2016 in October, one that significantly expands its geographic footprint and adds a new line of services to its pediatric healthcare business. The target, Norcross, Georgia-based Pediatria Healthcare for Kids, provides pediatric home health care services to medically complex children. It operates 29 locations across eight states, offering pediatric private duty nursing and... Read More »Q3:16 Health Care M&A Results: Context Is Everything
Brace yourself. The third quarter results for health care mergers and acquisitions signal a hard tap on the brakes, both in deal volume and value. That’s compared with the robust second quarter, and the same quarter a year ago. Before we go any further, though, we must note that, compared with all previous third quarters stretching back to 2000, the third quarter of 2016 doesn’t look that bad. Some 369 transactions are now on the books for Q3:16, which ranks this quarter as the second-highest in deal volume for any previous third quarter. The top-ranked third quarter, coincidently, came a year ago, when Q3:15 racked up 411 transactions. So Q3:16’s deal volume slid 10% compared with the... Read More »Pharmacy Software Companies Merge
Specialty pharmacies have attracted a lot of interest from private equity firms in 2016. Now it’s specialty pharmacy services companies that are beginning to see consolidation. In October, Rx30, a portfolio company of GTCR since June 2015, merged with another pharmacy software supplier, privately held Computer Rx. Rx30 develops and supplies pharmacy management software solutions to the independent, hospital, long-term care and specialty pharmacy markets. Computer Rx has a similar focus, which includes community pharmacies. Rx30’s CEO Steve Wubker will lead the combined business. Roger Warkentine, founder of Computer Rx, will continue as an advisor to the combined business, and... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
